Skip to content

Study on the Efficacy of a Non-Invasive Wearable Brain-Computer Interface Mouse in Improving Care for Patients with Upper Limb Dysfunction Due to Motor Neuron Disease

Study on the Efficacy of Brain-Computer Interface Mouse system in Improving Care for Patients with Upper Limb Dysfunction Due to Motor Neuron Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091712
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-11-02
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

motor neuron disease (MND)

Interventions

Experimental Group:Subjects operated a computer using a wearable non-invasive brain-computer interface mouse system for 10 days, once a day for no less than 15 minutes

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with motor neuron disease (MND) at Peking University Third Hospital between October 2024 and October 2025, meeting the revised 1998 ALS El Escorial diagnostic criteria; aged 18 to 70 years; with an FRS-R score greater than 24 (with upper limb function score = 4, corresponding to items 4-7 on the scale); and who agree to and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with a history of other central nervous system diseases, such as cerebrovascular disease or Parkinson's syndrome, as well as a history of psychiatric disorders or head trauma; patients with frontotemporal degeneration who are unable to cooperate with the use of the equipment; patients concurrently participating in other clinical studies; and those who are unable to comprehend or cooperate with this clinical study.

Design outcomes

Primary

MeasureTime frame
the MOS item short from health survey (SF-36);The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40);

Secondary

MeasureTime frame
Self-Depression Scale;Patient Activation Measure 13;Self-Rating Anxiety Scale (SAS);Zarit Burden Interview (ZBI);NASA Task Load Index (NASA-TLX);

Countries

China

Contacts

Public ContactWang Liping

Peking University Third Hospital

dianer@126.com+86 186 2088 3682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026